N/A
Completed N=161
Virtual Immersive Communication Training on Recommending Immunizations
Human Papilloma Virus
Source: ClinicalTrials.gov NCT04368455 ↗
Enrolled (actual)
161
Serious AEs
0.0%
Results posted
Apr 2023
Primary outcomePrimary: Percent Change From Baseline in the Percentage of Participants With HPV Vaccine Initiation — 18.1; 3.9 Percent Change from Baseline
Summary
Our approach will be to implement Virtual Immersive Communication Training on Recommending Immunizations (VICTORI), an intervention that includes a self-directed app based curriculum and VR simulations, designed to increase the strength and consistency of HPV vaccine recommendations among clinicians. A single-site intervention assessing the efficacy of VICTORI in increasing HPV vaccine rates will be conducted.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Change From Baseline in the Percentage of Participants With HPV Vaccine Initiation |
18.1; 3.9 | — |
| SECONDARY Physicians Perceived Barriers |
7.39; 6.87; 6.75 | — |
| SECONDARY Physicians Perceived Risk |
10.53; 12.07; 11.36 | — |
| SECONDARY Physicians Attitudes Toward the HPV Vaccine |
49.68; 54.24; 53.15 | — |
| SECONDARY Physicians Strength of Recommendation of the HPV Vaccine |
28.49; 28.76; 29.17 | — |
| SECONDARY Physicians Self-efficacy |
7.44; 9.55; 9.27 | — |
Eligibility Criteria
Inclusion Criteria
- Physician (Attending or Resident) at control or intervention clinic
- Staff Member (Medical Assistant or Nurse) at intervention clinic
Exclusion Criteria
- N/A
Data sourced from ClinicalTrials.gov (NCT04368455). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.